32.9 C
Delhi
Saturday, May 15, 2021

Mumbai corporation approves Remdesivir at double the rate agreed by Maha undertaking

- Advertisement -

MohFW recommends Remdesivir and HCQ for Covid casesNew Delhi, April 14 (IANS) Two tenders for Remdesivir injections in Maharashtra approved by government departments have gone at completely divergent prices, raising questions on how the procurements are being done.

One tender has been passed at double the rate approved in another tender by two separate government undertakings/departments under the Maharashtra government.

Haffkine Bio Pharmaceuticals, a government of Maharashtra undertaking, approved an online tender by Cadila Healthcare for Rs 665.84 per vial of Remdesivir injection. The total quantity was 57,100 vials for Rs 3.80 crore approved on April 9.

Contrasted with this, the Municipal Corporation of Greater Mumbai has approved a tender by Mylan Labs at the rate of Rs 1,568 per vial on April 7 which is more than double the cost of the bid approved by Haffkine Bio.

READ ALSO:  Using oxygen concentrator without medical guidance can be harmful: Experts

The Mylan tender is for 2 lakh vials and the injections will be supplied to the hospitals and Covid centres in Mumbai.

Remdisivir is used for Covid treatment and it is running in short supply. There have also been reports of black marketing of Remdesivir.

Source: IANS

India Updates
India Updates is an independent news & Information website. Follow us for regular updates on News and Information.

Follow Us On

READ ALSO:  United Nation's recognition for Kerala in fight against Covid-19

Related News

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Trending Topics In India

Covid 19 India Updates

Trending News In India

Trending Showbiz

Trending Sports

Latest Trending News In India